Clinical Trial Update: Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ZD1839 (Iressa) in combination with Tamoxifen for breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Iressa (gefitinib)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED